A detailed history of True Mark Investments, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, True Mark Investments, LLC holds 13,158 shares of NVO stock, worth $1.42 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
13,158
Previous 13,447 2.15%
Holding current value
$1.42 Million
Previous $1.92 Billion 18.38%
% of portfolio
0.5%
Previous 0.66%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$119.07 - $145.42 $34,411 - $42,026
-289 Reduced 2.15%
13,158 $1.57 Billion
Q2 2024

Jul 29, 2024

BUY
$122.71 - $146.91 $1.65 Million - $1.98 Million
13,447 New
13,447 $1.92 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track True Mark Investments, LLC Portfolio

Follow True Mark Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Mark Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Mark Investments, LLC with notifications on news.